Overview

Antiplatelet Therapy in Chronic Urticaria

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
This study compares the combination of antiplatelets and antihistamine versus antihistamine alone for the treatment of chronic spontaneous urticaria
Phase:
PHASE2
Details
Lead Sponsor:
Chulalongkorn University
Treatments:
Cilostazol
desloratadine
Dipyridamole
Histamine Antagonists